Target intelligence / Profile preview

Major histocompatibility complex class II antigen presentation pathway (MHC class II antigen presentation)

Target
MHC class II antigen presentation
Molecular classification
Other (Biological pathway, not a single molecule), If referring to component molecules: Immunoglobulin superfamily, Transmembrane glycoprotein, Receptor (for MHC class II molecules themselves)
01

Overview

The MHC class II antigen presentation pathway is a central process in the adaptive immune response, in which specialized antigen-presenting cells such as dendritic cells, macrophages, and B cells internalize exogenous antigens (from pathogens or the environment), process these proteins into peptides, and load the resulting fragments onto MHC class II molecules. These peptide-MHC class II complexes are then displayed on the cell surface, where they are recognized by CD4\(^+\) T cells, triggering their activation and differentiation. This pathway is fundamental for the initiation of immune responses against extracellular pathogens and for the regulation of immune tolerance, and its dysfunction is associated with autoimmune disease, infection, and cancer. If you need structured details for a molecule rather than a pathway, specify the particular MHC class II molecule (such as "HLA-DR" or "HLA-DQ").

Other names
MHC class II pathwayHLA class II pathway (human-specific)Antigen presentation to CD4\(^+\) T cellsMHC-II-mediated antigen presentation
02

Mechanism of action

Inhibition of proteases (e.g., cathepsin S inhibitors prevent peptide loading onto MHC class II molecules); Broad immunosuppression (reduced antigen presentation by APCs); Blockade of co-stimulatory signals, preventing T cell activation

03

Biological functions

Immune responseAntigen presentationT cell activation and differentiationInduction of antibody production by B cellsMaintenance of immune self-toleranceAutoimmunity regulation
04

Disease associations

Autoimmune disease (e.g., Type 1 diabetes, Celiac disease, rheumatoid arthritis)Infection (role in response to bacterial, viral, and parasitic pathogens)Cancer (immune surveillance and immune therapies)Inflammation
05

Safety considerations

Immunosuppression (risk of infections and decreased cancer surveillance)Increased risk of autoimmunity (aberrant or excessive antigen presentation)Hypersensitivity reactions (e.g., heightened immune activation)
06

Interacting drugs

Cathepsin S inhibitors (block antigen processing and loading onto MHC class II)

2 more in the full profile.

07

Biomarkers

MHC class II molecule expression levels (e.g., HLA-DR)Specific HLA class II alleles (risk for autoimmune diseases, e.g., HLA-DQ2 for Celiac disease)Costimulatory molecule expression (CD80, CD86)APC activation markers

Beyond the preview

Go deeper on Major histocompatibility complex class II antigen presentation pathway (MHC class II antigen presentation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major histocompatibility complex class II antigen presentation pathway (MHC class II antigen presentation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call